Medically reviewed by Dr. Shweta Agarwal, MBBS, DGO. Last updated: June 2026.
Information on this page is educational and does not replace a medical consultation. Outcomes depend on individual clinical factors.
What is the difference between menopause, perimenopause, and premature ovarian insufficiency?
Menopause is a clinical milestone: 12 uninterrupted months without a period, confirming the permanent end of ovarian oestrogen and progesterone cycling. The average age of natural menopause globally is usually between 45 and 55 years; Indian cohort studies commonly report an average around 46 years, with variation by region and study population (per WHO 2024; Indian menopause epidemiology studies). Perimenopause is the variable transition phase before menopause — lasting months to several years — during which cycles become irregular, hormone levels fluctuate, and menopausal symptoms may begin even while periods continue. Premature Ovarian Insufficiency (POI) describes loss of normal ovarian function before the age of 40, including irregular or absent periods combined with hormonal changes consistent with menopause. POI is clinically distinct: unlike natural menopause, ovarian function in POI is not always permanently lost. Some women with POI experience intermittent ovarian activity and, occasionally, spontaneous conception — though this cannot be relied upon.
In Marathi and Hindi, menopause is often called रजोनिवृत्ती (rajonivritti), a word your doctor may use during consultation.
What symptoms are associated with menopause and perimenopause?
The symptoms of perimenopause and menopause result from declining and fluctuating oestrogen and progesterone. They vary widely between individuals — some women experience minimal disruption, others significant. The most common include:
- Irregular periods: Cycles that were previously regular may become shorter, longer, heavier, lighter, or unpredictable. This is often the first sign of perimenopause.
- Absent periods: In established menopause or POI, periods stop entirely.
- Hot flushes: Sudden sensations of warmth, often affecting the face, neck, and chest, sometimes with sweating and palpitations.
- Sleep disturbance: Difficulty falling or staying asleep, sometimes related to night sweats.
- Mood changes: Irritability, low mood, or anxiety that is new or worsened. These are recognised physiological effects, not purely psychological.
- Vaginal dryness and discomfort: Reduced oestrogen affects vaginal tissue and moisture.
- Reduced libido.
- Difficulty concentrating or memory lapses: Often described informally as "brain fog."
- Joint aches.
Symptoms are not diagnostic on their own — evaluation with blood tests is needed to confirm what is happening hormonally.
How is menopause or POI diagnosed?
Diagnosis is clinical and hormonal, and the process differs slightly depending on whether the concern is natural menopause, perimenopause, or POI.
Clinical history
Dr. Shweta Agarwal will take a detailed history of your menstrual pattern — when cycles changed, how, for how long — alongside your symptoms, any relevant medical history (e.g. autoimmune conditions, prior surgery, chemotherapy), and family history of early menopause.
Blood hormone tests
The core hormonal tests include:
- FSH (Follicle-Stimulating Hormone): Rises as the ovaries produce less oestrogen. An elevated FSH on two occasions (at least four weeks apart) is a key marker for POI.
- Oestradiol (E2): Typically low in menopause and POI.
- AMH (Anti-Müllerian Hormone): Reflects ovarian reserve — the pool of remaining eggs. A low or undetectable AMH is consistent with POI or diminished ovarian reserve. See our low AMH page and blog post on what AMH means and what low AMH implies.
- LH, thyroid function, prolactin: To rule out other causes of cycle disruption.
Antral follicle count (AFC)
A transvaginal ultrasound can count the small resting follicles in the ovaries. A low AFC alongside low AMH and elevated FSH forms a consistent picture of reduced ovarian reserve. Book a fertility assessment to have these investigations done in-house.
Confirming POI
For a formal diagnosis of POI, elevated FSH (above the laboratory's menopausal threshold) on at least two tests, four weeks apart, in a woman under 40 with irregular or absent periods, is required. A single result is insufficient.
What causes early menopause and premature ovarian insufficiency?
In many cases the cause is not identified — POI is idiopathic in a significant proportion of women. Where a cause is found, the main categories are:
Genetic causes
- Turner syndrome (45,X): A chromosomal condition in which one X chromosome is absent or structurally altered, affecting ovarian development.
- Fragile X premutation: Women who carry a premutation in the FMR1 gene (on the X chromosome) are at substantially elevated risk of POI. Fragile X premutation testing is recommended for women with unexplained POI, particularly where there is a family history.
- Other chromosomal variants affecting ovarian development.
Autoimmune causes
The immune system can produce antibodies against ovarian tissue, destroying follicles. This may occur in isolation or as part of a broader autoimmune condition (e.g. autoimmune thyroid disease, Addison's disease). An autoimmune screen is part of a thorough POI workup.
Iatrogenic causes (treatment-related)
This is a well-recognised and often anticipated cause:
- Chemotherapy: Alkylating agents (e.g. cyclophosphamide) and certain other regimens are gonadotoxic — they damage ovarian follicles. The degree of damage depends on the agent, dose, and the woman's age and baseline reserve.
- Pelvic radiotherapy: Radiation to or near the pelvis can impair ovarian function.
- Ovarian surgery: Procedures for ovarian cysts (especially bilateral or repeated surgeries for endometriomas) can reduce ovarian reserve.
Women facing any of these treatments should be referred promptly for fertility preservation counselling — see oncofertility.
Idiopathic
In many women with POI, no cause is found despite thorough investigation.
What are the fertility implications of early menopause and POI?
This is often the central concern for women of reproductive age diagnosed with POI or perimenopause with significantly reduced ovarian reserve. The picture is nuanced:
POI is not absolute sterility. Unlike natural menopause, POI does not always mean the ovaries have permanently stopped. Intermittent ovarian activity occurs in a proportion of women with POI, and occasional spontaneous pregnancies have been documented. However, relying on this is not a fertility strategy — ovarian function is unpredictable and declines over time.
Declining ovarian reserve limits IVF with own eggs. The number and quality of eggs available for retrieval in a stimulated IVF cycle depends on ovarian reserve (AMH, AFC). When reserve is very low, the response to stimulation may be poor, reducing the chances of obtaining embryos with own eggs. An honest, individualised assessment is needed — see our page on low AMH for more on this, and our blog post on IVF, age, and realistic expectations.
Earlier evaluation is protective. For women in perimenopause with declining (but not yet exhausted) reserve, earlier fertility evaluation opens more options. If a future pregnancy is desired and reserve is falling, earlier planning is clinically sensible. This is educational information, not a pressure tactic.
Fertility preservation before gonadotoxic treatment (oncofertility). For women diagnosed with cancer or other conditions requiring chemotherapy or pelvic radiotherapy, fertility preservation before treatment starts is a recognised, time-sensitive option. Options include:
- Egg (oocyte) freezing — eggs retrieved and vitrified before treatment.
- Embryo freezing — fertilised embryos vitrified; requires a partner or donor sperm.
- Oncofertility pathway — specialist coordinated care between oncology and fertility teams.
Donor egg IVF (education-only information). For women whose own ovarian reserve is exhausted or very low, IVF using donated oocytes is a recognised treatment pathway that substantially changes the prognosis — because the age and quality of the egg (not the uterus) is the dominant factor in IVF outcomes, using eggs from a younger donor changes the reproductive biology significantly. Aansh Hospital & IVF Center holds ART Bank registration (Reg. No. MH/AB/2024/11445/Chandrapur/91). This information is educational. Donor use is regulated under the ART Act 2021; details are discussed in a clinical consultation and through our registrations page. No recruitment of donors takes place on this page.
What are the options for managing menopause symptoms?
Fertility-related management is covered above. For symptoms of menopause and perimenopause more broadly, the established approaches include:
- Hormone Replacement Therapy (HRT): Replacing declining oestrogen (and, in women with a uterus, progesterone) can substantially reduce hot flushes, sleep disturbance, mood symptoms, and vaginal dryness. In women with POI under natural menopause age, HRT is generally recommended to protect bone density and cardiovascular health until the age of natural menopause. The appropriateness of HRT, its form, and its duration should be discussed with your clinician — Dr. Shweta Agarwal can guide you on this.
- Non-hormonal options: Certain medications and lifestyle approaches (exercise, temperature regulation, sleep hygiene) have evidence for symptom benefit and are relevant for women who cannot or prefer not to use hormonal treatment.
- Bone health: Long-term oestrogen deficiency increases fracture risk. Calcium, vitamin D, and bone density monitoring are part of the long-term care plan for women with POI.
- Mental health support: The emotional impact of an early menopause or POI diagnosis — particularly in younger women, and especially where fertility is a concern — should not be underestimated. Counselling is part of holistic care.
This page does not provide a management plan — it provides orientation. Your doctor is the right person to discuss the balance of options for your specific situation.
When should I see a specialist about menopause, POI, or declining fertility?
You should consult Dr. Shweta Agarwal promptly if:
- You are under 40 and your periods have become irregular, infrequent, or stopped.
- You are experiencing hot flushes, significant sleep disruption, or mood changes alongside cycle changes — particularly if you are in your 30s.
- You have a known genetic risk factor for POI (family history of early menopause, Fragile X premutation carrier status).
- You have been told your AMH is low or that your ovarian reserve is diminished — see low AMH.
- You are about to start chemotherapy or pelvic radiotherapy and have not yet spoken with a fertility specialist.
- You are in your late 30s or early 40s, your cycles are changing, and future pregnancy is important to you — earlier assessment preserves more options.
- A blood test elsewhere has shown a raised FSH.
Early assessment does not commit you to any treatment — it gives you information. A fertility assessment at Aansh can include AMH, FSH, oestradiol, and an antral follicle count, conducted in-house.